CTI BioPharma
CTIC
#5214
Rank
ยฃ0.92 B
Marketcap
ยฃ7.00
Share price
0.00%
Change (1 day)
23.77%
Change (1 year)

Revenue for CTI BioPharma (CTIC)

Revenue in 2023 (TTM): ยฃ63.38 Million

According to CTI BioPharma 's latest financial reports the company's current revenue (TTM ) is ยฃ58.36 Million. In 2022 the company made a revenue of ยฃ44.59 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CTI BioPharma from 1997 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ63.38 M42.15%
2022 ยฃ44.59 M
2021 N/A
2020 N/A-100%
2019 ยฃ2.55 M-87.51%
2018 ยฃ20.42 M9.75%
2017 ยฃ18.6 M-60.01%
2016 ยฃ46.52 M327.79%
2015 ยฃ10.87 M-71.82%
2014 ยฃ38.58 M83.55%
2013 ยฃ21.02 M
2012 N/A
2011 N/A-100%
2010 ยฃ0.2 M317.99%
2009 ยฃ0.04 M-99.37%
2008 ยฃ7.8 M12101.49%
2007 ยฃ0.06 M56.52%
2006 ยฃ0.04 M-99.56%
2005 ยฃ9.33 M-39.46%
2004 ยฃ15.41 M11.35%
2003 ยฃ13.84 M31.38%
2002 ยฃ10.53 M145%
2001 ยฃ4.3 M1178.62%
2000 ยฃ0.33 M81.17%
1999 ยฃ0.18 M-97.66%
1998 ยฃ7.93 M10.51%
1997 ยฃ7.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ25.06 B 42,838.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ36.53 B 62,504.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.13 B 5,279.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.55 B 19,693.06%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.47 B 53,831.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.54 B 21,399.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ38.46 B 65,810.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland